PRQR · ProQR Therapeutics N.V
United States · RS rating 21 · As of 2026-11-03
| Price | 1.37 USD |
|---|---|
| 1-day change | +3.8% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 23 / 20 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 4 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +62.7% |
| Distance from 52-week high | +47.1% |
| Market cap (USD) | $171.7M |